Sitemorse - building web confidence

Follow us on Twitter
LOG IN
Across your e-disciplines, we offer unique support.

Global Life Sciences Qtr 1 2010

Organisation Rank Function Accessibility Code quality Performance Email Metadata Analytics Spelling PDFs
Neurimmune Therapeutics AG 1   Satisfactory: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available No score available No score available
Lipideon Biotechnology AG 2   Satisfactory: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available Satisfactory: Mark remained the same No score available No score available No score available
Medinova AG 3   Satisfactory: Mark rose Impaired: Mark rose Satisfactory: Mark rose Satisfactory: Mark rose Satisfactory: Mark dropped Impaired: Mark remained the same No score available No score available No score available
OMIDA AG 4   Impaired: Mark dropped Impaired: Mark rose Satisfactory: Mark dropped Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark rose No score available No score available Impaired: Mark remained the same
Nycomed Pharma AG 5   Satisfactory: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
AmVac AG 6   Satisfactory: Mark remained the same Impaired: Mark rose Impaired: Mark remained the same Satisfactory: Mark rose No score available Compromised: Mark dropped No score available No score available Impaired: Mark remained the same
Helsinn Healthcare S.A. 7   Satisfactory: Mark remained the same Impaired: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark rose Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
Newron 8   Satisfactory: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark rose Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
Alpex Pharma SA 9   Satisfactory: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available No score available Satisfactory: Mark remained the same
ArisGen SA 10   Satisfactory: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark rose Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available No score available
Siegfried AG 11   Impaired: Mark rose Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
BioPartners GmbH 12   Impaired: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available No score available
Axenoll AG 13   Impaired: Mark remained the same Impaired: Mark rose Impaired: Mark rose Satisfactory: Mark remained the same No score available Impaired: Mark remained the same No score available No score available No score available
4-Antibody AG 14   Impaired: Mark rose Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available No score available Impaired
Biogen Idec International GmbH 15   Satisfactory: Mark remained the same Impaired: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark rose Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available No score available Impaired: Mark remained the same
Arpida AG 16   Impaired: Mark dropped Impaired: Mark rose Satisfactory: Mark rose Satisfactory: Mark remained the same Impaired: Mark dropped Compromised: Mark dropped No score available No score available Impaired: Mark remained the same
Kuros Biosurgery AG 17   Satisfactory: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Compromised: Mark remained the same Satisfactory Compromised: Mark remained the same No score available No score available Impaired: Mark remained the same
AC Immune SA 18   Impaired: Mark rose Compromised: Mark remained the same Satisfactory: Mark rose Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available No score available Impaired: Mark dropped
Johnson & Johnson Pharmaceutical Research & Development 19   Satisfactory: Mark rose Impaired: Mark remained the same Compromised: Mark remained the same Impaired: Mark rose Satisfactory: Mark remained the same Impaired: Mark dropped No score available No score available Impaired: Mark remained the same
Tricom GmbH, Pharma Division 20   Satisfactory: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same No score available No score available No score available
BioVersys GmbH 21   Satisfactory: Mark remained the same Impaired: Mark remained the same Impaired: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available No score available
Cytos Biotechnology AG 22   Impaired: Mark remained the same Impaired: Mark rose Impaired: Mark remained the same Satisfactory: Mark rose Impaired: Mark dropped Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
Helvepharm AG 23   Impaired: Mark remained the same Impaired: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available No score available No score available
Evolva SA 24   Impaired: Mark dropped Impaired: Mark remained the same Satisfactory: Mark rose Satisfactory: Mark dropped Impaired: Mark dropped Compromised: Mark remained the same No score available No score available Impaired: Mark remained the same
Galenica Ltd. 25   Satisfactory: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same No score available Satisfactory: Mark remained the same No score available No score available Impaired: Mark remained the same
Anavex Life Sciences Corp. 26   Impaired: Mark dropped Compromised: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark dropped No score available No score available Impaired: Mark dropped
Auris Medical AG 27   Satisfactory: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available No score available
Max Zeller Söhne AG 28   Impaired: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Compromised: Mark remained the same No score available No score available Impaired: Mark remained the same
GKL Biotec AG 29   Impaired: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same No score available No score available Impaired: Mark remained the same
Basilea Pharmaceutica Ltd. 30   Satisfactory: Mark rose Impaired: Mark remained the same Impaired: Mark rose Satisfactory: Mark remained the same Satisfactory: Mark dropped Compromised: Mark remained the same No score available No score available Impaired: Mark remained the same
Neurotune 31   Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
Med Discovery S.A. 32   Satisfactory: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark remained the same Compromised: Mark remained the same No score available No score available Satisfactory: Mark remained the same
Vifor (International) Ltd. 33   Impaired: Mark dropped Compromised: Mark remained the same Impaired: Mark rose Satisfactory: Mark remained the same No score available Satisfactory: Mark remained the same No score available No score available Impaired: Mark remained the same
CSL Behring AG 34   Impaired: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available Satisfactory: Mark remained the same
Actelion Ltd. 35   Impaired: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available No score available Satisfactory: Mark remained the same
Novartis International AG 36   Compromised: Mark rose Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark dropped Satisfactory: Mark remained the same No score available No score available Impaired: Mark rose
Addex Pharmaceuticals 37   Compromised: Mark remained the same Impaired: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same No score available Compromised: Mark remained the same No score available No score available Impaired: Mark remained the same
Ferring International Center SA 38   Impaired: Mark remained the same Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark dropped Compromised: Mark dropped Satisfactory: Mark dropped No score available No score available Impaired: Mark dropped
Aurora Pharma GmbH 39   Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark rose Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
Lunamed AG 40   Satisfactory: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Compromised: Mark remained the same No score available No score available Impaired: Mark remained the same
F. Hoffmann-La Roche AG Switzerland 41   Compromised: Mark rose Impaired: Mark rose Satisfactory: Mark rose Satisfactory: Mark remained the same Compromised: Mark dropped Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
Covagen AG 42   Compromised: Mark dropped Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available No score available
GlycoVaxyn AG 43   Compromised: Mark dropped Compromised: Mark dropped Satisfactory: Mark rose Satisfactory: Mark remained the same Impaired Satisfactory: Mark rose No score available No score available Impaired: Mark rose
Merck Serono International SA 44   Compromised: Mark dropped Compromised: Mark dropped Satisfactory: Mark dropped Satisfactory: Mark rose Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available Satisfactory: Mark dropped
Bayer Schweiz AG 45   Compromised: Mark dropped Compromised: Mark remained the same Impaired: Mark rose Satisfactory: Mark remained the same Impaired: Mark remained the same Compromised: Mark remained the same No score available No score available Impaired: Mark remained the same
Crucell | Berna Biotech Ltd 46   Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
Valeant Pharmaceuticals Switzerland GmbH 47   Compromised Impaired Compromised Satisfactory No score available Impaired No score available No score available Impaired
Medipol SA 48   Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark rose Impaired: Mark remained the same No score available No score available Impaired: Mark dropped
Ergonex Pharma GmbH 49   Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available Satisfactory: Mark remained the same No score available No score available Impaired: Mark remained the same
Gruenenthal Pharma AG 50   Compromised: Mark remained the same Compromised: Mark dropped Impaired: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same No score available No score available Satisfactory: Mark rose
Nitec Pharma AG 51   Impaired: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark dropped Compromised: Mark remained the same Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
AstraZeneca AG 52   Impaired: Mark dropped Compromised: Mark remained the same Compromised: Mark rose Satisfactory: Mark remained the same Satisfactory: Mark rose Satisfactory: Mark remained the same No score available No score available Impaired: Mark remained the same
Novartis Pharma Schweiz AG 53   Compromised: Mark rose Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark dropped Satisfactory: Mark remained the same No score available No score available Impaired: Mark remained the same
Spirig Pharma AG 54   Impaired: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Impaired: Mark rose Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
PharmaSwiss SA - HQ 55   Satisfactory: Mark remained the same Compromised: Mark rose Impaired: Mark rose Impaired: Mark dropped Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available Satisfactory: Mark remained the same
3-V Biosciences GmbH 56   Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available No score available
Debiopharm S.A. 57   Compromised: Mark dropped Compromised: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark rose Satisfactory: Mark remained the same No score available No score available Satisfactory: Mark remained the same
NovImmune 58   Compromised: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Impaired: Mark remained the same No score available Satisfactory: Mark remained the same No score available No score available Impaired: Mark remained the same
Neurim Pharmaceuticals S.A. 59   Impaired: Mark remained the same Compromised: Mark remained the same Compromised: Mark remained the same Impaired: Mark rose Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available Satisfactory: Mark remained the same
GeNeuro SA 60   Impaired: Mark remained the same Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Compromised: Mark dropped Satisfactory: Mark remained the same No score available No score available Impaired: Mark remained the same
Permamed AG 61   Compromised: Mark remained the same Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same No score available Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
Kenta Biotech AG 62   Compromised: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Compromised: Mark dropped Satisfactory: Mark remained the same No score available No score available Satisfactory: Mark dropped
Octapharma AG 63   Impaired: Mark remained the same Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark rose Compromised: Mark dropped Satisfactory: Mark remained the same No score available No score available Impaired: Mark remained the same
Antares Pharma AG 64   Compromised: Mark remained the same Compromised: Mark remained the same Compromised: Mark remained the same Impaired: Mark rose Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available No score available Impaired: Mark rose
F. Hoffmann-La Roche AG Global 65   Compromised: Mark remained the same Impaired: Mark remained the same Compromised: Mark dropped Satisfactory: Mark rose Impaired: Mark rose Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
Merck Sharp & Dohme-Chibret AG 66   Compromised: Mark remained the same Compromised: Mark remained the same Impaired: Mark rose Impaired: Mark remained the same Satisfactory: Mark remained the same Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
Solvay Pharma AG 67   Impaired Compromised Compromised Impaired Impaired Satisfactory No score available No score available Satisfactory
Nycomed International Management GmbH 68   Compromised: Mark remained the same Impaired: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark dropped Impaired: Mark rose Impaired: Mark remained the same No score available No score available Impaired: Mark dropped
ESBATECH AG 69   Compromised: Mark remained the same Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available No score available Impaired: Mark dropped
mondoBIOTECH AG 70   Compromised: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark rose Impaired: Mark rose Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
Baxter Switzerland 71   Compromised: Mark dropped Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark rose Satisfactory: Mark remained the same Impaired: Mark dropped No score available No score available Impaired: Mark dropped
Schwabe Pharma AG 72   Impaired: Mark remained the same Compromised: Mark remained the same Compromised: Mark rose Satisfactory: Mark remained the same No score available Compromised: Mark remained the same No score available No score available Impaired: Mark remained the same
Streuli Pharma AG 73   Impaired: Mark remained the same Compromised: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same No score available No score available No score available
Mepha Pharma AG 74   Compromised: Mark remained the same Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark dropped Compromised: Mark remained the same No score available No score available Impaired: Mark remained the same
Cryo-Save AG 75   Impaired: Mark remained the same Compromised: Mark remained the same Compromised: Mark remained the same Impaired: Mark rose Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available No score available No score available
GenKyoTex SA 76   Compromised: Mark dropped Compromised: Mark remained the same Compromised: Mark remained the same Satisfactory: Mark rose Impaired: Mark remained the same Impaired: Mark remained the same No score available No score available Impaired: Mark remained the same
OM PHARMA 77   Compromised: Mark remained the same Compromised: Mark remained the same Compromised: Mark remained the same Impaired: Mark remained the same Satisfactory: Mark remained the same Satisfactory: Mark remained the same No score available No score available Impaired: Mark remained the same

Changes in rank are compared to Qtr 4 2009 (Global Life Sciences). Since then, 2 sites entered the survey and 11 sites could not be included in the rankings (1 more since last time).

Surveys

Qtr 2 2013

Police Forces

First
Cleveland Police
Last
South Wales Police
Up 23
South Yorkshire Police
Down 38
Leicestershire Constabulary

Qtr 2 2013

Universities

First
University Campus Suffolk (UCS)
Last
Norwich City College of Further and Higher Education (an Associate College of UEA)
Up 168
South Nottingham College
Down 162
The University of Salford